160 related articles for article (PubMed ID: 15062176)
21. Erectile dysfunction after prostate three-dimensional conformal radiation therapy. Correlation with the dose to the penile bulb.
Magli A; Giangreco M; Crespi M; Negri A; Ceschia T; De Giorgi G; Titone F; Parisi G; Fongione S
Strahlenther Onkol; 2012 Nov; 188(11):997-1002. PubMed ID: 23053160
[TBL] [Abstract][Full Text] [Related]
22. Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy.
McDonald AM; Baker CB; Shekar K; Popple RA; Clark GM; Yang ES; Jacob R; Kim RY; Fiveash JB
Urology; 2014 Dec; 84(6):1383-7. PubMed ID: 25440987
[TBL] [Abstract][Full Text] [Related]
23. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
Wernicke AG; Valicenti R; Dieva K; Houser C; Pequignot E
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1357-63. PubMed ID: 15590165
[TBL] [Abstract][Full Text] [Related]
24. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review.
van der Wielen GJ; Mulhall JP; Incrocci L
Radiother Oncol; 2007 Aug; 84(2):107-13. PubMed ID: 17707936
[TBL] [Abstract][Full Text] [Related]
25. Radiation therapy for prostate cancer and erectile (dys)function: the role of imaging.
Incrocci L
Acta Oncol; 2005; 44(7):673-8. PubMed ID: 16227156
[TBL] [Abstract][Full Text] [Related]
26. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
[TBL] [Abstract][Full Text] [Related]
27. A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone.
Papagikos MA; Rossi PJ; Urbanic JJ; deGuzman AF; McCullough DL; Clark PE; Lee WR
Am J Clin Oncol; 2007 Apr; 30(2):199-204. PubMed ID: 17414471
[TBL] [Abstract][Full Text] [Related]
28. Erectile function durability following permanent prostate brachytherapy.
Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
[TBL] [Abstract][Full Text] [Related]
29. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma.
Brown MW; Brooks JP; Albert PS; Poggi MM
Prostate Cancer Prostatic Dis; 2007; 10(2):189-93. PubMed ID: 17189954
[TBL] [Abstract][Full Text] [Related]
30. The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer.
Stember DS; Mulhall JP
Brachytherapy; 2012; 11(2):87-96. PubMed ID: 22330103
[TBL] [Abstract][Full Text] [Related]
31. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
Lehrer S; Cesaretti J; Stone NN; Stock RG
BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
[TBL] [Abstract][Full Text] [Related]
32. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
Selek U; Cheung R; Lii M; Allen P; Steadham RE; Vantreese TR; Little DJ; Rosen II; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1039-46. PubMed ID: 15234037
[TBL] [Abstract][Full Text] [Related]
33. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial.
van der Wielen GJ; Hoogeman MS; Dohle GR; van Putten WL; Incrocci L
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):795-800. PubMed ID: 18164862
[TBL] [Abstract][Full Text] [Related]
34. An age-corrected matched-pair study of erectile function in patients treated with dose-escalated adaptive image-guided intensity-modulated radiation therapy vs. high-dose-rate brachytherapy for prostate cancer.
Marina O; Warner J; Ye H; Grills IS; Shah C; Wallace M; Gustafson GS; Brabbins DS; Martinez AA; Krauss DJ
Brachytherapy; 2014; 13(2):163-8. PubMed ID: 24295963
[TBL] [Abstract][Full Text] [Related]
35. Baseline status and dose to the penile bulb predict impotence 1 year after radiotherapy for prostate cancer.
Cozzarini C; Rancati T; Badenchini F; Palorini F; Avuzzi B; Degli Esposti C; Girelli G; Improta I; Vavassori V; Valdagni R; Fiorino C
Strahlenther Onkol; 2016 May; 192(5):297-304. PubMed ID: 27079673
[TBL] [Abstract][Full Text] [Related]
36. ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Rodda S; Tyldesley S; Morris WJ; Keyes M; Halperin R; Pai H; McKenzie M; Duncan G; Morton G; Hamm J; Murray N
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):286-295. PubMed ID: 28433432
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
Peng LC; Mian OY; Lakshminarayanan P; Huang P; Bae HJ; Robertson S; Habtu T; Narang A; Agarwal S; Greco S; Tran P; McNutt T; DeWeese TL; Song DY
Urology; 2020 Jan; 135():111-116. PubMed ID: 31454660
[TBL] [Abstract][Full Text] [Related]
38. Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.
Keyes M; Pickles T; Crook J; McKenzie M; Cheung A; Spadinger I; LaPointe V; Bachand WF; Morris J
Brachytherapy; 2015; 14(3):334-41. PubMed ID: 25684438
[TBL] [Abstract][Full Text] [Related]
39. Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer.
Rasmusson E; Gunnlaugsson A; Wieslander E; Höglund P; Widmark A; Fransson P; Kjellén E; Nilsson P
Int J Radiat Oncol Biol Phys; 2020 May; 107(1):143-151. PubMed ID: 32004582
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial.
Murray J; Gulliford S; Griffin C; Wilkins A; Syndikus I; Staffurth J; Panades M; Scrase C; Parker C; Khoo V; Dean J; Mayles H; Mayles P; Thomas S; Naismith O; Mossop H; Cruickshank C; Hall E; Dearnaley D;
Clin Transl Radiat Oncol; 2020 Mar; 21():77-84. PubMed ID: 32072028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
